Original Article

You have full text access to this OnlineOpen article

Prognosis and pathology of screen-detected carcinomas

How different are they?

  1. Iris D. Nagtegaal MD, PhD1,
  2. Prue C. Allgood PhD3,†,*,
  3. Stephen W. Duffy MSc3,
  4. Olive Kearins2,
  5. E. O. Sullivan BSc2,
  6. Nancy Tappenden MPH2,
  7. Matthew Wallis MB, ChB, FRCR4,
  8. Gill Lawrence PhD2

Article first published online: 2 NOV 2010

DOI: 10.1002/cncr.25613

Issue

Cancer

Cancer

Volume 117, Issue 7, pages 1360–1368, 1 April 2011

Additional Information

How to Cite

Nagtegaal, I. D., Allgood, P. C., Duffy, S. W., Kearins, O., Sullivan, E. O., Tappenden, N., Wallis, M. and Lawrence, G. (2011), Prognosis and pathology of screen-detected carcinomas. Cancer, 117: 1360–1368. doi: 10.1002/cncr.25613

Author Information

  1. 1

    Department of Pathology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

  2. 2

    West Midlands Cancer Intelligence Unit, Birmingham, United Kingdom

  3. 3

    CR-UK Center for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, United Kingdom

  4. 4

    Cambridge Breast Screening Unit and National Institute for Health Research, Cambridge Biomedical Research Center, Addenbrooke's Hospital Cambridge, United Kingdom

  1. †

    Fax: (011) 44-2078823890

*CR-UK Centre for EMS, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, United Kingdom

Publication History

  1. Issue published online: 18 MAR 2011
  2. Article first published online: 2 NOV 2010
  3. Manuscript Accepted: 28 JUL 2010
  4. Manuscript Received: 20 MAY 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (321K)

REFERENCES

  • 1
    Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organised service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006; 15: 45-51.
  • 2
    Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organised service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev. 2006; 15: 52-56.
  • 3
    Paci E, Duffy SW, Giorgi D, et al. Are breast cancer screening programmes increasing rates of mastectomy? Observational study. Br Med J. 2002; 325: 418.
  • 4
    Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW. Overdiagnosis, sojourn time and sensitivity in the Copenhagen Mammography Screening Programme. Breast J. 2006; 12: 338-342.
    Direct Link:
  • 5
    Alexander FE, Anderson TJ, Hubbard AL. Screening status in relation to biological and chronological characteristics of breast cancers: a cross-sectional survey. J Med Screen. 1997; 4: 152-157.
  • 6
    Gilliland FD, Joste N, Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst. 2000; 92: 743-749.
  • 7
    Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen HHT. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004; 42: 793-806.
  • 8
    Anderson TJ, Lamb J, Donnan P, et al. Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer. 1991; 64: 108-113.
  • 9
    Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999; 91: 2020-2028.
  • 10
    Webster LR, Bilous AM, Willis L, et al. Histopathologic indicators of breast cancer biology: insights from population mammographic screening. Br J Cancer. 2005; 92: 1366-1371.
  • 11
    Duffy SW, Tabar L, Fagerberg G, et al. Breast screening, prognostic factors and survival—results from the Swedish two-county study. Br J Cancer. 1991; 64: 1133-1138.
  • 12
    Lawrence G, O'Sullivan E, Kearins O, Tappenden N, Martin K, Wallis M. Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10 year survival. J Med Screen. 2009; 16: 186-192.
  • 13
    StataCorp. Stata release 9: user's guide. College Station, TX: Stata Press; 2005.
  • 14
    Breslow NE, Day NE. Statistical methods in cancer research. volume 1: the analysis of case-control studies. Lyon, France: IARC; 1981.
  • 15
    Collett, D. Modelling survival data in medical research. New York, NY: Chapman and Hall; 1994.
  • 16
    Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Stat Med. 1992; 11: 167-178.
    Direct Link:
  • 17
    Lindgren A, Holmberg L, Thurfjell E. The influence of mammography screening on the pathological panorama of breast cancer. APMIS 1997; 105: 62-70.
    Direct Link:
  • 18
    Ernst MF, Roukema JA, Coebergh JWW, et al. Breast cancers found by screening: earlier detection, lower malignant potential or both? Breast Cancer Res Treat. 2002; 76: 19-25.
  • 19
    Jensen AR, Garne JP, Storm HH, et al. Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations. Acta Oncol. 2003; 42: 701-709.
  • 20
    Thomson CS, Brewster DH, Dewar JA, Twelves CJ. Improvements in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. Eur J Cancer. 2004; 40: 743-753.
  • 21
    Shen Y, Yang Y, Inoue LYT, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomised screening trials. J Natl Cancer Inst. 2005; 97: 1195-1203.
  • 22
    Ng EH, Ng FC, Tan PH, et al. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women. Cancer. 1998; 82: 1521-1528.
    Direct Link:
  • 23
    Anderson TJ, Waller M, Ellis IO, Bobrow L, Moss S. Influence of annual mammography from age 40 on breast cancer pathology. Hum Pathol. 2004; 35: 1252-1259.
  • 24
    Johnson A, Shekhdar J. Does breast cancer grade worsen with time? Evidence from breast screening. Breast Cancer Res Treat. 2001; 68: 261-271.
View Full Article (HTML) Get PDF (321K)